Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 315 JPY -1.65% Market Closed
Market Cap: 32.5B JPY

Fuji Pharma Co Ltd's latest stock split occurred on Jun 27, 2018

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, Fuji Pharma Co Ltd traded at 3950 per share. Afterward, the share price was about 1726.7347.

The adjusted shares began trading on Jun 27, 2018. This was the only stock split in Fuji Pharma Co Ltd's history.

Last Splits:
Jun 27, 2018
2-for-1
Pre-Split Price
1 746.1859 3 950
Post-Split Price
1 726.7347
Before
After
Last Splits:
Jun 27, 2018
2-for-1

Fuji Pharma Co Ltd
Stock Splits History

Fuji Pharma Co Ltd Stock Splits Timeline
Jun 27, 2018
Jun 27, 2018
Split 2-for-1
x2
Pre-Split Price
1 746.1859 3 950
Post-Split Price
1 726.7347
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 1, 2025
I
Icon Energy Corp
NASDAQ:ICON
1-for-40
/40
0.0478 1.912 USD 1.79 1.79 USD
Apr 1, 2025
V
Vortex Energy Corp
CNSX:VRTX
1-for-10
/10
0.075 0.075 CAD 0.11 0.11 CAD
Apr 1, 2025
R
Resource Centrix Holdings Inc
CNSX:RECE
10-for-1
x10
2.4 0.24 CAD 0.24 0.24 CAD
Apr 1, 2025
V
Vortex Energy Corp
OTC:VTECF
1-for-10
/10
0.05 0.5 USD 0.0378 0.0378 USD
Mar 31, 2025
Utime Ltd
NASDAQ:WTO
1-for-10
/10
0.151 1.51 USD 1.58 1.58 USD
Load More

Fuji Pharma Co Ltd
Glance View

Market Cap
32.1B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
2 076.26 JPY
Undervaluation 37%
Intrinsic Value
Price
Back to Top